Karen Armour, MD
Family Medicine · Covington, TNNPI 1700822368
Payments from drug & device makers
Across 104 payments — averaging $18.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$478
- AstraZeneca$326
- Merz North America, Inc.$240
- Lilly USA, LLC$213
- Mylan Specialty L.p.$168
- Boehringer Ingelheim$122
- plus $409 from 15 others
What the payments were for
- Food & beverage$1,94599%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 25 | $478 |
| AstraZeneca | 19 | $326 |
| Merz North America, Inc. | 1 | $240 |
| Lilly USA, LLC | 15 | $213 |
| Mylan Specialty L.p. | 12 | $168 |
| Boehringer Ingelheim | 8 | $122 |
| Axsome Therapeutics, Inc. | 3 | $75 |
| Sunovion Pharmaceuticals Inc. | 3 | $66 |
| Merck | 4 | $59 |
| Abbott | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $27 |
| Scilex Pharmaceuticals Inc. | 1 | $20 |
| Genentech USA, Inc. | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| GSK | 1 | $15 |
| Vyera Pharmaceuticals, LLC | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $13 |
| Pfizer | 1 | $13 |
| AbbVie | 1 | $12 |
| Bayer | 1 | $12 |
| Dexcom, Inc. | 1 | $12 |
How this compares
$1,956 in reported general payments places this provider in the 65th percentile of 2,087 family medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $736 |
| Potassium Chloride | 11 | $551 |
| Atorvastatin Calcium | 23 | $309 |
| Rosuvastatin Calcium | 11 | $306 |
| Losartan Potassium | 24 | $300 |
| Omeprazole | 19 | $283 |
| Pioglitazone Hcl | 12 | $202 |
| Hydrochlorothiazide | 17 | $132 |
| Metformin Hcl | 15 | $104 |
| Amlodipine Besylate | 13 | $89 |
| Levocetirizine Dihydrochloride | 12 | $71 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Covington
- Rickey ManningKnoxville$8.1M
- Kymberly MoyerGallatin$5.9M
- Natasha BallardChattanooga$5.7M
- Hina BudhwaniNashville$4.7M
- Paul WakefieldKnoxville$4.3M
- Emily HubbsKingsport$2.8M
- Jerry PunchKnoxville$2.1M
- Bridgette FraneyNashville$2M
- Andrew BrockmyreBristol$1.8M
- Marcus LeeTullahoma$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.